Name: ELANCO ANIMAL HEALTH INC (ELAN) Stock
Brand: ELANCO ANIMAL HEALTH INC
Rating: 7 (3 reviews)

ELAN Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: Elanco Animal Health

Elanco Investor Day Defines New Era as Sustainable Growth Company

a month ago - By: Benzinga - Mentions: CAH GH MEDP WGS ...

6 Healthcare Stocks With Strong Upward Momentum

a month ago - By: Zacks Investment Research

Are Options Traders Betting on a Big Move in Elanco Animal Health Stock?

a month ago - By: Elanco Animal Health

Elanco's Credelio™ CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats

a month ago - By: The Motley Fool - Mentions: NICE HOLX PSMT PYPL ...

Black Creek’s Stake Reduction and the Larger Transition Unfolding Inside NICE’s Cloud and AI Platform

a month ago - By: Elanco Animal Health

Elanco Animal Health Reports Third Quarter 2025 Results

a month ago - By: Benzinga - Mentions: TECH INSE GEF SKYT ...

Earnings Scheduled For November 5, 2025

2 months ago - By: Zacks Investment Research - Mentions: USPH

ELAN vs. USPH: Which Stock Is the Better Value Option?

2 months ago - By: Elanco Animal Health

Elanco to Host Investor Day on December 9

a month ago - By: Zacks Investment Research

Compared to Estimates, Elanco Animal Health (ELAN) Q3 Earnings: A Look at Key Metrics

a month ago - By: Zacks Investment Research - Mentions: ASTH

Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates

a month ago - By: Investor's Business Daily - Mentions: IDXX ZTS

How Idexx Laboratories Business Shook Off Bears And Hit A Record

2 months ago - By: Zacks Investment Research

Elanco Animal Health Incorporated (ELAN) Reports Next Week: What You Should Expect

2 months ago - By: Elanco Animal Health

Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

2 months ago - By: Elanco Animal Health

Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

3 months ago - By: Zacks Investment Research

ELANCO ANIMAL HEALTH INC (ELAN) Stock News

ELAN Latest News, Press Relases and Analysis

Elanco Investor Day Defines New Era as Sustainable Growth Company

6 Healthcare Stocks With Strong Upward Momentum

Are Options Traders Betting on a Big Move in Elanco Animal Health Stock?

Elanco's Credelio™ CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats

Black Creek’s Stake Reduction and the Larger Transition Unfolding Inside NICE’s Cloud and AI Platform

Elanco Animal Health Reports Third Quarter 2025 Results

Earnings Scheduled For November 5, 2025

ELAN vs. USPH: Which Stock Is the Better Value Option?

Elanco to Host Investor Day on December 9

Compared to Estimates, Elanco Animal Health (ELAN) Q3 Earnings: A Look at Key Metrics

Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates

How Idexx Laboratories Business Shook Off Bears And Hit A Record

Elanco Animal Health Incorporated (ELAN) Reports Next Week: What You Should Expect

Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

Elanco Animal Health (ELAN) Upgraded to Buy: What Does It Mean for the Stock?